TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...

The quest to mitigate disability progression in multiple sclerosis (MS) has long been hindered by our limited understanding ...

People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or ...

Children most affected by MS-related biological aging appeared to be aging up to two years faster than kids without MS, even ...

People are using cannabis for everything from pain to insomnia. Here’s when it might help and when it won’t. And don’t smoke ...

Before making changes to your diet, it’s a good idea to speak to your doctor or a qualified dietitian to make sure you don’t ...

LACMA gets ready to show its new David Geffen Galleries, reviews of 'Queer Lens' at the Getty and 'Parade' at the Ahmanson.

Yann Echelard, Director at TG Therapeutics TGTX , disclosed an insider sell on June 16, according to a recent SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange ...

Also known as colour vision deficiency (CVD), the condition is said to affect three million people in the UK alone, working ...